Skip to content
Clinical Trials – home
Not yet recruiting

Effect of acetylcysteine plus simeticone pre‑medication on gastric visibility in patients undergoing upper endoscopy with chromoendoscopy

Registered drugNo placebo
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

What is this trial about?

A plain-language summary of the goals, design and what participants do

The study involves people who are scheduled for an upper gastrointestinal endoscopy, a procedure in which a thin tube with a camera is passed through the mouth to look at the lining of the stomach and esophagus. Before the exam, participants will receive a combination of two medicines: N-acetylcysteine, which helps thin mucus, and simethicone, which reduces gas bubbles. The combination is referred to as GASTROprep and is taken as an oral solution about 30 to 60 minutes before the endoscopy.

The purpose of the study is to find out whether taking this pre‑medication improves how clearly the stomach lining can be seen during the exam. After taking the medicine, participants will go through the standard endoscopy, during which the doctor may clean the area with water if needed and may take small tissue samples, called biopsies, to examine under a microscope. The clarity of the stomach lining will be scored using a simple rating system known as the Barcelona scale, and any extra cleaning steps or side effects will be recorded.

Participants will stay in the clinic for the short time needed for the medication to work and for the endoscopy itself. After the procedure, they will be asked about any discomfort or unusual symptoms, and the medical team will monitor for any adverse reactions. The overall length of the endoscopy, the number of biopsies taken, and the findings will be noted, but no additional visits or special tests are required beyond the routine exam.

The research process

The trial runs in 7 steps – from screening to follow-up. Each step says what happens and what the team monitors.

  1. Step 1

    Receive Study Medications and Instructions

    After joining the study, you will be given a medication kit that contains acetylcysteine 600 mg in oral solution form and simethicone 225 mg in oral emulsion form.

    Written instructions will explain how to take each product and the timing required before the endoscopic examination.

  2. Step 2

    Take Acetylcysteine

    Dissolve the 600 mg dose of acetylcysteine in a small amount of water and drink it as a single dose.

    The dose should be taken 30 to 60 minutes before the scheduled upper gastrointestinal endoscopy.

  3. Step 3

    Take Simethicone

    Consume the 225 mg dose of simethicone using the provided oral emulsion.

    This dose is also taken 30 to 60 minutes before the endoscopy, and it may be taken together with the acetylcysteine dose.

  4. Step 4

    Wait Before the Procedure

    After taking both medications, wait the required 30–60 minutes before arriving for the examination.

    During this period you should follow any fasting or fluid‑restriction instructions that were given.

  5. Step 5

    Undergo Upper Gastrointestinal Endoscopy

    You will undergo a high‑quality upper gastrointestinal endoscopy with chromoendoscopy.

    The doctor will assess the visibility of the gastric lining using the Barcelona Scale. If the view is not clear, additional washing of the stomach may be performed.

  6. Step 6

    Post‑Procedure Observation

    After the endoscopy, you will be observed for a short period to detect any side effects such as nausea, vomiting, or allergic reactions.

    Any adverse events will be recorded by the study team.

  7. Step 7

    Complete Study Participation

    No further study medication is required after the endoscopy.

    Your involvement in the trial ends after the post‑procedure observation and data collection are completed.

Who can join the trial?

2 criteria

  • Be 18 years old or older and able to understand and sign a consent form (informed consent means agreeing to join after being told what will happen)
  • Be an outpatient who has an appointment for an upper gastrointestinal endoscopy (a test where a thin tube with a camera looks at the esophagus, stomach, and the start of the small intestine) with chromoendoscopy (a technique that uses special dyes to make the lining easier to see) at the participating hospital’s endoscopy unit

Who cannot join the trial?

8 criteria

  • You must be at least 18 years old; anyone younger cannot join.
  • If you are pregnant, you cannot take part in the study.
  • If you have a very high risk from anesthesia, called ASA IV (a classification indicating serious health problems that make anesthesia risky), you cannot join.
  • If you have had previous gastric surgery that changes the shape or structure of your stomach, you are not eligible.
  • If a therapeutic procedure (a treatment planned for you) is already scheduled, you cannot participate.
  • If you need a therapeutic endoscopy (an endoscopy that is meant to treat a condition) or an urgent (emergency) procedure, you cannot join.
  • If you have an allergy to any part of the medication or a contraindication (a reason why the medication should not be used for you), you cannot take part.
  • If you cannot follow the required fasting requirements (not eating or drinking before the test) or cannot take the study medication as instructed, you are not eligible.
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.

We usually reply within a few days

Trial locations

Where you can join this trial

Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.

Not yet recruiting
Not finding your country?

Not sure what to do next?

Joining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.

See the full process and FAQ

Investigated drugs

  • N‑acetylcysteine

    is a medication that helps thin and break down thick mucus in the stomach. In this study it is given by mouth a short time before the endoscopy so that the lining of the stomach becomes clearer and easier for the doctor to see. By reducing the amount of mucus, it improves the visibility of any abnormal areas and helps the doctor make a more accurate diagnosis.

  • Simethicone

    is an oral medicine that reduces gas bubbles in the stomach and intestines. When taken before the endoscopy, it helps eliminate tiny pockets of air that can create a hazy view on the camera. This makes the stomach lining look smoother and cleaner, allowing the doctor to examine the tissue more effectively.

What is already known about the treatment

  • Acetylcysteine

    Acetylcysteine is taken by mouth as a powder that is mixed with water to form a liquid or as an effervescent tablet that dissolves in water, creating an oral solution. It is a well‑known drug that is widely used to thin thick mucus in the lungs and to protect the stomach lining, and it has been studied extensively in medical literature. The molecule works by breaking the sticky bonds in mucus and by providing a building block that helps the body make a natural antioxidant. It is classified as a mucolytic and antioxidant agent.

  • Simethicone

    Simethicone is administered orally as a liquid emulsion that is swallowed directly or mixed with a small amount of water. It is an over‑the‑counter medication that has been used for many years to reduce gas and bloating, and its safety and effectiveness are well documented. It works by lowering the surface tension of gas bubbles, allowing them to join together and be expelled more easily. It belongs to the class of anti‑foaming agents.

Investigated diseases

  • Gastric mucosal lesions

    These are abnormal changes in the lining of the stomach that can develop gradually over time. They often begin as inflammation and may progress to thinning of the stomach lining, known as atrophy. Continued irritation can lead to the replacement of normal cells with intestinal-type cells, a process called intestinal metaplasia. If the metaplastic area expands, it can form small growths called gastric adenomas. Over many years, these adenomas can evolve into early-stage gastric cancer if left unchecked.

  • Esophageal lesions

    These refer to abnormal areas in the lining of the esophagus that may appear as red patches, ulcers, or raised growths. They frequently start with chronic irritation from acid reflux, leading to inflammation. Persistent inflammation can cause the cells to change their appearance, a condition known as Barrett’s esophagus. The altered cells may develop into dysplasia, a precancerous state. With ongoing cellular changes, dysplasia can advance to early esophageal cancer.

Trial detailsLast updated 17 Nov 2026
Age18+ yearsPhasePhase IIITrial ID2026-526469-42-00Protocol codeGASTROprepEstimated enrolment182 patientsSponsorFundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana

sourced from the EU Clinical Trials Register and site verification

Want to learn more about this trial or check if you can participate?

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.